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Abstract
Peripheral inflammation induces persistent central sensitization characterized by mechanical
allodynia and heat hyperalgesia that are mediated by distinct mechanisms. Compared to well-
demonstrated mechanisms of heat hyperalgesia, mechanisms underlying the development of
mechanical allodynia and contralateral pain are incompletely known. In this study, we investigated
the distinct role of spinal JNK in heat hyperalgesia, mechanical allodynia, and contralateral pain in
an inflammatory pain model. Intraplantar injection of complete Freund’s adjuvant (CFA) induced
bilateral mechanical allodynia but unilateral heat hyperalgesia. CFA also induced a bilateral
activation (phosphorylation) of JNK in the spinal cord, and the phospho JNK1 (pJNK1) levels were
much higher than that of pJNK2. Notably, both pJNK and JNK1 were expressed in GFAP-positive
astrocytes. Intrathecal infusion of a selective peptide inhibitor of JNK, D-JNKI-1, starting before
inflammation via an osmotic pump, reduced CFA-induced mechanical allodynia in the maintenance
phase but had no effect on CFA-induced heat hyperalgesia. A bolus intrathecal injection of D-JNKI-1
or SP600126, a small molecule inhibitor of JNK also reversed mechanical allodynia bilaterally. In
contrast, peripheral (intraplantar) administration of D-JNKI-1 reduced the induction of CFA-induced
heat hyperalgesia but did not change mechanical allodynia. Finally, CFA-induced bilateral
mechanical allodynia was attenuated in mice lacking JNK1 but not JNK2. Taken together, our data
suggest that spinal JNK, in particular JNK1 plays an important role in the maintenance of persistent
inflammatory pain. Our findings also reveal a unique role of JNK1 and astrocyte network in regulating
tactile allodynia and contralateral pain.
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1. Introduction
Increasing evidence indicates that mitogen-activated protein kinases (MAPKs), including
extracellular signal-regulated kinases (ERKs), p38, and c-Jun N-terminal kinases (JNK), play
important roles in persistent pain sensitization after tissue and nerve injuries [17,26,28,53].
These MAPKs also have multiple isoforms, such as ERK1, ERK2, ERK5, p38α, p38β, p38γ,
p38δ, JNK1, JNK2, and JNK3 [33]. Currently available inhibitors do not distinguish among
different isoforms. By using antisense oligodeoxynucleotides and RNA interference, the role
of some isoforms, such as ERK2, ERK5, and p38β in inflammatory pain has been revealed
[36,63,68]. However, the specific role of different JNK isoforms in inflammatory pain remains
elusive.
Tissue damage-induced inflammatory pain is characterized by heat hyperalgesia (increased
responsiveness to noxious stimuli) and mechanical allodynia (painful responses to normally
innocuous stimuli). It is generally believed that peripheral mechanisms, such as activation of
transient receptor potential (TRP) and sodium channels in primary sensory neurons, play an
essential role in the induction of heat hyperalgesia [34,67]. But the mechanisms underlying the
development of mechanical allodynia are not well defined. It appears that central sensitization
and large Aβ fiber activation are important for the induction of mechanical allodynia [29,41,
55,67]. Importantly, mechanical allodynia is more characteristic than thermal hypersensitivity
in chronic pain conditions. Mechanical allodynia is not only produced in the injured tissue, but
also spread to the adjacent non-injured regions and even contralateral side [38,47,67]. For
example, mechanical allodynia develops in the contralateral paws after CFA inflammation
[3,5,51,57]. Further, inflammation produces bilateral increase in the phosphorylation of the
transcription factor cAMP response element binding protein (CREB) [30,45] and expression
of cyclooxygenase-2 (COX2) [59] in the spinal cord.
Accumulating evidence indicates that spinal cord astrocytes become reactive after nerve injury
and CFA inflammation [1,14,57,71]. Upon activation, astrocytes may promote pain by
producing cytokines [e.g., interleukin-1β (IL-1β)] [20]) and chemokines [e.g., monocyte
chemoattractant protein-1 (MCP-1)] [18]. Astrocytes are characterized by forming astroglial
networks (gap junctions) between them [19]. Interestingly, gap junction blocker carbenoxolone
suppresses “mirror pain” (mechanical allodynia) in the contralateral paw [62]. In a previous
study we showed that intrathecal injection of L-alpha-aminoadipate, a cytotoxin for astrocytes,
can reverse nerve injury-induced mechanical allodynia [71]. Further, nerve injury activates
JNK in spinal astrocytes, and intrathecal infusion of JNK inhibitors effectively attenuates nerve
injury-induced mechanical allodynia [71]. In the present study, we investigated whether JNK,
in particular JNK1 in spinal astrocytes has a distinct role in regulating inflammation-induced
heat hyperalgesia, mechanical allodynia, and contralateral pain (spread of pain).
2. Materials and Methods
2.1 Animals
Male adult Sprague Dawley rats (220–260 g), CD1 mice (20–30 g), and mice lacking Jnk1
(JNK1−/−) and Jnk2 (JNK2−/−), obtained from Jackson Laboratories with C57/Bl6 genetic
background, and their littermate control mice, were used in this study. All animal studies were
performed under Harvard Medical School Animal Care institutional guidelines. Peripheral
inflammation was induced by intraplantar injection of CFA (Sigma, 100 μl for rats and 20 μl
for mice) in the left hind paws under brief anesthesia with sevofluorane.
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2.2 Drug administration
The peptide inhibitor of JNK, D-JNKI-1was provided by Dr. Christophe Bonny, University of
Lausanne, Switzerland [6] and dissolved in saline. JNK inhibitor SP600125 was purchased
from Calbiochem and dissolved in 10% DMSO. For single intrathecal injection, spinal cord
puncture was made under brief sevofluorane anesthesia with a 30 gauge needle between the
L5 and L6 level to deliver the reagents (20μl for rats) to the CSF [71]. The doses of JNK
inhibitors we used for bolus injection (0.1–4 nmol of D-JNKI-1 and 20 nmol of SP600125)
and pump infusion (100 μM of D-JNKI-1) were based on our previous study [71]. Immediately
after the needle entry into subarachnoid space (change in resistance), a brisk tail flick could be
observed. For sustained spinal drug infusion in rats, osmotic pumps (1μl/h for 7 days, Alzet,
Cupertino, CA) were implanted under the back skin. Each pump was connected to a
polyethylene (PE10) catheter that was inserted into subarachnoid space between L5-L6
vertebrate. The drug filled pumps were soaked in saline for 3 h before implantation [25].
2.3 Western blots
As described previously [70], animals were rapidly killed after deep anesthesia with isoflurane,
and the L4-5 spinal segments from both sides were quickly removed and homogenized in a
SDS sample buffer containing a mixture of proteinase and phosphatase inhibitors (Sigma).
Protein samples (25 μg) were separated on SDS-PAGE gel and transferred to nitrocellulose
blots. The blots were blocked with 5% milk and incubated overnight at 4°C with antibody
against phosphorylated JNK (pJNK, rabbit, 1:1000; Cell Signaling), phosphorylated c-Jun
(rabbit, 1:300; Cell Signaling), JNK (rabbit, 1:1000; Cell Signaling), GAPDH (mouse,
1:20000; Millipore), and β-tubulin (mouse, 1:5000; Sigma). These blots were further incubated
with HRP-conjugated secondary antibody, developed in ECL solution, and exposed onto
Hyperfilm (Amersham Biosciences) for 1–10 min. Specific bands were evaluated by apparent
molecular size. The intensity of the selected bands was captured and analyzed using Image J
software (NIH).
2.4 Immunohistochemistry
Animals were terminally anesthetized with isoflurane and perfused through the ascending aorta
with saline followed by 4% paraformaldehyde/1.5% picric acid. After the perfusion, the spinal
cord segments (L4-5) were removed and postfixed in the same fixative overnight, then replaced
with 15% sucrose overnight. Spinal sections (transverse, free-floating, 30 μm) were cut in a
cryostat. For double immunostaining of pJNK and GFAP, the sections were blocked with 2%
goat serum in 0.3% Triton for 1 h at RT and incubated over night at 4°C with a mixture of
primary antibodies (anti-pJNK, 1:1000, rabbit, cell signaling; and anti-GFAP, 1:5000, mouse,
Millipore). The sections were then incubated for 1 h at RT with a mixture of Cy3- and FITC-
conjugated secondary antibodies (1:400, Jackson ImmunoResearch). For double staining of
JNK1 and GFAP, the Tyramide Signaling Amplification (TSA) kit (PerkinElmer) was used to
amplify immunofluorescence signal of JNK1. The spinal sections were blocked with TNB
buffer and incubated with JNK1 antibody (1:1000; rabbit, Cell Signaling) overnight at 4°C,
followed by a biotinylated secondary antibody (1:200) for 2 h at room temperature. The sections
were then incubated with StreptaAvidin (1:100) for 30 min and FITC-conjugated tyramide
(1:50) for 10 min at room temperature. After JNK1 immunostaining, the sections were further
processed with GFAP immunostaining with a mouse-anti-GFAP antibody (1:5000; Millipore).
The stained sections were examined with a Nikon fluorescence microscope, and images were
captured with a CCD Spot camera.
2.5 Behavioral analysis
Animals were habituated to the testing environment daily for at least 2 d before baseline testing.
The room temperature and humidity remained stable for all experiments. For testing
Gao et al. Page 3
Pain. Author manuscript; available in PMC 2010 February 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
mechanical sensitivity, animals were put under inverted plastic boxes (11×13×24 cm) on an
elevated mesh floor and allowed 30 min for habituation, before the threshold testing.
Mechanical allodynia was tested using von Frey hairs. The paw was pressed with one of a
series of von Frey hairs with logarithmically incrementing stiffness (0.6, 1, 1.4, 2, 4, 6, 8, 10,
15, and 26 g for rats, and 0.02, 0.04, 0.08, 0.16, 0.32, 0.64, 1.28, and 2.56 g for mice) (Stoelting,
Kiel, WI), presented perpendicular to the plantar surface. Each hair was applied for 5–6 s on
rats and 1–2 s on mice [41]. The 50% withdrawal threshold was determined using Dixon’s up–
down method [9]. For testing heat sensitivity, animals were put in a plastic box placed on a
glass plate, and the plantar surface was exposed to a beam of radiant heat through a transparent
Perspex surface [22]. The baseline latencies were adjusted to 12–15 sec with a maximum of
20 sec as cutoff to prevent potential injury. The latencies were averaged over three trials,
separated by a 3 min interval.
2.6 Quantification and statistics
For the quantification of Western Blot, the density of specific bands for pJNK1 and JNK1 (46
kDa), pJNK2 and JNK2 (54 kDa), p-c-Jun, β-tubulin, and GAPDH was measured with imaging
analysis software (Image J, NIH). The size of rectangle was fixed for each band and the
background near that band was subtracted. pJNK1/2 or JNK1/2 levels were normalized to
loading controls (β-tubulin or GAPDH). The Western data were analyzed with one way
ANOVA followed by Newman-Keuls test for post hoc analysis. For behavioral studies, the
data of paw withdrawal latencies and paw withdrawal thresholds (determined by up-down
method) passed normality test, thus were suitable for parametric statistics. The data were
analyzed with student’s t-test (two groups only) or one way ANOVA followed by Newman-
Keuls test for post hoc analysis. All the data were presented as mean ± SEM, and P<0.05 was
considered statistically significant in all cases.
3. Results
3.1 Time course of inflammation-induced bilateral mechanical allodynia and unilateral heat
hyperalgesia
Unilateral injection of 100 μl of undiluted CFA into a hindpaw of rats produces marked
inflammation and inflammatory pain [25,31]. CFA-induced mechanical allodynia on the
ipsilateral paw was very rapid (< 1 hour) (Fig. 1A). The paw withdrawal threshold (PWT)
dropped from 18.5 ± 2.5 g before CFA injection (baseline) to 0.7 ± 0.1 g at 1 hour after CFA
injection. The mechanical allodynia remained at the peak level for more than 14 d. Mechanical
allodynia was also found in the contralateral paws. But the contralateral allodynia was delayed,
starting at 3 h, and the magnitude of allodynia in the contralateral paws was also smaller than
that on the ipsilateral paws (Fig. 1A).
CFA also induced rapid (< 1 h) heat hyperalgesia (Fig. 1B). The heat hyperalgesia peaked at
6 h. The paw withdrawal latency (PWL) decreased from 13.1 ± 0.6 s before inflammation to
3.3 ± 0.3 s at 6 h after CFA injection. Unlike mechanical allodynia, heat hyperalgesia largely
recovered at 14 d, although PWL was still lower than that of the baseline. Strikingly, heat
hyperalgesia was exclusively unilateral: there was no change in PWLs in the contralateral paws
at all the time points examined (Fig. 1B). Consistently, we did not notice any obvious sign of
inflammation in the contralateral paws, suggesting that the CFA model we produced is a
monoarthritis model.
3.2 Bilateral activation of JNK in the spinal cord after CFA inflammation
Like other MAPKs JNK is activated by phosphorylation [17]. Thus, we examined JNK
phosphorylation at different times after inflammation. Western blot analysis showed a low
level of basal phosphorylation of JNK1/2. Notably, the basal pJNK1 (46 kDa) levels were much
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higher than basal pJNK2 (52 kDa) levels (Fig. 2A,B). According to the time course of CFA-
induced pain behavior, we examined JNK activation in the bilateral lumbar spinal cord (L4-5)
at 6 h, 1 d, 3 d, 7 d, and 14 d after CFA injection. CFA induced a rapid increase in pJNK1 and
pJNK2 levels in both the ipsilateral (Fig. 2A) and contralateral (Fig. 2B) spinal cord. The
increase in pJNK1 and pJNK2 started at 6 h and maintained at 14 d (Fig. 2A,B). In contrast,
total levels (phosphorylated plus non-phosphorylated) of JNK1 and JNK2 did not change after
CFA (Fig. 2C), indicating that increases in pJNK levels result from increases in JNK
phosphorylation. Although both pJNK1 and pJNK2 increased after inflammation, pJNK1
levels were much higher than pJNK2 levels at all the time points examined (Fig. 2A,B),
suggesting that pJNK1 is the predominant form of pJNK in the spinal cord.
3.3 Expression of pJNK and JNK1 in spinal cord astrocytes
Immunohistochemistry also reveal an increase in pJNK immunoreactivity in the superficial
spinal cord after inflammation (Fig. 3A,B). Double staining further indicated that pJNK was
exclusively colocalized with GFAP (Fig. 3C), a cellular marker for astrocytes. Thus, pJNK is
also expressed in spinal cord astrocytes after inflammation, in support of previous studies in
neuropathic conditions [42,71]. Furthermore, JNK1 was expressed GFAP-positive astrocytes
in the spinal cord (Fig. 3D–F), again in agreement with previous studies [35,71].
3.4 Inhibition of CFA-induced mechanical allodynia in the maintenance phase by intrathecal
pretreatment of a peptide inhibitor of JNK
To determine the role of JNK in inflammatory heat hyperalgesia and mechanical allodynia, we
inhibited the action of JNK with a highly selective JNK inhibitor, D-JNKI-1, which does not
affect the activity of >40 other kinases including ERK and p38 [6]. D-JNKI-1 is a peptide
derived from JNK binding domain of JNK-interacting protein-1 (JIP-1), and selectively blocks
the access of JNK to its substrates by a competitive mechanism (Fig. 4A). Further, a 10-amino
acid HIV Tat (48–57) transporter sequence is linked to the JBD of JIP-1 so that the peptide is
cell membrane permeable. Finally, a convert to D-form amino acids makes the peptide resistant
to proteinases (Fig. 4A) [6].
To examine whether D-JNKI-1 can prevent inflammatory pain, we infused D-JNKI-1 at a low
concentration (100 μM) via intrathecal osmotic pump (1 μl/h) for 1 week, starting 2 d before
CFA injection. Notably, a previous study used a much higher concentration of SP600125 (8
mM) for pump infusion [54]. Intrathecal infusion of D-JNKI-1 to spinal fluid did not change
basal paw withdrawal threshold (Fig. 4B) and paw withdrawal latency (Fig. 4C) tested before
CFA injection (P>0.05), indicating that JNK does not regulate basal pain perception. Neither
did D-JNKI-1 affect the induction of mechanical allodynia tested at 6 h after CFA injection
(Fig. 4B). However, mechanical allodynia in the maintenance phase (day 1 to day 4) was
attenuated by D-JNKI-1. Two days after the pump infusion stopped, mechanical allodynia
developed again on day 7 (Fig. 4B). We can not exclude the possibility that the peptide inhibitor
is degraded over time at the body temperature. In sharp contrast, CFA-induced heat
hyperalgesia on the ipsilateral paws was not altered by the inhibitor at all the time points
examined (Fig. 4C).
3.5 Reverse of bilateral mechanical allodynia by intrathecal inhibition of JNK
To further determine whether spinal JNK is required for the maintenance of inflammatory pain,
we applied a bolus injection of D-JNKI-1 intrathecally (i.t.) on post-CFA day 3 and tested
mechanical and heat sensitivity 3 h after the injection. Our previous study showed that D-
JNKI-1 produced the best anti-allodynic effect at 3 h after bolus injection in the spinal nerve
ligation model [71]. D-JNKI-1 produced a dose-dependent reversal of mechanical allodynia
in both ipsilateral and contralateral paws (ipsilateral, P < 0.01; contralateral, P < 0.01). Even
a low dose (0.4 nmol) of D-JNKI-1 had a significant anti-allodynic effect (P < 0.05). Strikingly,
Gao et al. Page 5
Pain. Author manuscript; available in PMC 2010 February 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the anti-allodynic effect of D-JNKI-1 was more robust on the contralateral side, compared to
the ipsilateral side (Fig. 5A,B). D-JNKI-1 only reversed CFA-induced ipsilateral heat
hyperalgesia at a high dose (4 nmol) but not low doses (0.1 and 0.4 nmol) (Fig. 5C).
To confirm a specific role of JNK in the maintenance of inflammatory pain, we i.t. injected
another JNK inhibitor, SP600125 on post-CFA day 3. As D-JNKI-1, SP600125 (20 nmol)
partially reversed CFA-induced mechanical allodynia in both ipsilateral and contralateral paws
(Fig. 5D,E), with no effect on heat hyperalgesia (P > 0.05) (Fig. 5F). The data are also in
agreement with the previous report showing that D-JNKI-1 is more potent than SP600126 in
producing anti-allodynic action [71].
To determine whether the JNK pathway is inhibited by SP600125, we collected spinal cord
tissues after behavioral testing (3 h after drug injection) and examined the phosphorylation of
c-jun, a critical downstream target of JNK. Western blotting showed that SP600125
significantly reduced CFA-induced p-c-jun expression by 34% (P<0.05, Fig. 5G), suggesting
that the spinal JNK pathway is indeed inhibited by SP600125.
3.6 Attenuation of CFA-induced heat hyperalgesia by intraplantar inhibition of JNK
To examine whether JNK has a peripheral role in inflammatory pain, we injected D-JNKI-1
(10 nmol) into the plantar surface of a hindpaw, 30 min before CFA injection. This pretreatment
of D-JNKI-1 partially delayed the onset of CFA-induced heat hyperalgesia at 15 min, 3 h, and
6 h but not at 24 h (Fig. 6A). Pretreatment of intraplantar D-JNKI-1 had no effect on CFA-
induced mechanical allodynia (Fig. 6B). Further, posttreatment of intraplantar D-JNKI-1 (10
nmol) on post-CFA day 3 failed to alter heat hyperalgesia and mechanical allodynia (Fig. 6C,
D). These data suggest that peripheral JNK only contributes to the induction of inflammatory
heat hyperalgesia.
3.7 CFA-induced bilateral mechanical allodynia is attenuated in mice lacking JNK1 but not
JNK2
We also examined CFA-induced JNK activation in the spinal cord of mice. Like rats, mice
exhibited persistent increase of pJNK1 and pJNK2 in both the ipsilateral and contralteral spinal
cord. The increase started on day 1 and maintained on day 28. Although both pJNK1 and pJNK2
showed increases after inflammation, the pJNK1 levels were much higher than pJNK2 levels
(Fig. 7A–C), confirming that pJNK1 is the predominant form of pJNK in the mouse spinal
cord.
To define the distinct role of JNK1 and JNK2 in inflammatory pain, we examined CFA-induced
heat hyperalgesia and mechanical allodynia in Jnk1 or Jnk2 knockout mice. Like rats, wild-
type C57Bl6 mice exhibited a persistent (> 28 d) and bilateral mechanical allodynia (Fig. 8A)
and a transient (< 21 d) and unilateral heat hyperalgesia (Fig. 8B) following CFA inflammation.
In mice lacking JNK1, CFA-induced mechanical allodynia was partially but significantly
attenuated in both ipsilateral (Fig. 8A) and contralateral paws (Fig. 8B), especially in the
maintenance phase. In sharp contrast, CFA-induced heat hyperalgesia was comparable in
Jnk1 knockout mice and wild-type mice (Fig. 8C, D). In Jnk2 knockout mice, both CFA-
induced mechanical allodynia and heat hyperalgesia were comparable to that of wild-type mice
(Fig. 9A–D).
It is worthy to notice that the baseline thermal and mechanical thresholds in mice lacking JNK1
or JNK2 were not different from that of wild-type mice (Fig. 8 and 9), suggesting that JNK1
and JNK2 have no role in regulating pain sensitivity in normal conditions.
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Discussion
We have made several interesting findings in this study. First, unilateral CFA injection in a
hindpaw (monoarthritis) induced bilateral mechanical allodynia, bilateral JNK activation in
the spinal cord, but ipsilateral heat hyperalgesia. Second, intrathecal infusion of the JNK
inhibitors D-JNKI-1 and SP600125 at low doses, reduced CFA-induced mechanical allodynia
bilaterally in the maintenance phase, but had no effect on CFA-induced heat hyperalgesia.
Third, peripheral injection of D-JNKI-1 reduced CFA-induced heat hyperalgesia in the
induction phase without any effect on mechanical allodynia. Fourth, JNK1 was expressed in
spinal cord astrocytes and represented the predominant isoform of JNK in the spinal cord.
Finally, mice lacking JNK1 but not JNK2 exhibited reduced mechanical allodynia bilaterally
in the maintenance phase. These data indicate a unique role of spinal JNK1 in the maintenance
of mechanical allodynia.
4.1 Distinct roles of central and peripheral JNK in regulating mechanical allodynia and heat
hyperalgesia
Obata et al. showed that pre- and post-treatment of SP600125 reduced spinal nerve ligation
(SNL)-induced mechanical allodynia but failed to alter SNL-induced heat hyperalgesia [54].
Intrathecal infusion of a peptide inhibitor of JNK, D-JNKI-1 also attenuated SNL-induced
mechanical allodynia [71]. Compared to SP600125, D-JNKI-1 is more selective [6] and potent
in reversing nerve injury-induced mechanical allodynia [71]. The present study showed that
pretreatment of D-JNKI-1 via continuous i.t. infusion reduced CFA-induced mechanical
allodynia in the maintenance phase but failed to change CFA-induced heat hyperalgesia.
Posttreatment of D-JNKI-1 (0.4 and 4 nmol, i.t.) or SP600125 (20 nmol, i.t.) further reversed
mechanical allodynia, whereas heat hyperalgesia was only reduced by a high dose of D-JNKI-1
(4 nmol, i.t.). Our results further suggest spinal JNK is critical for maintaining mechanical
allodynia.
In contrast, peripheral administration of D-JNKI-1 in the hindpaw only reduced CFA-induced
heat hyperalgesia in the induction phase (Fig. 6). Intraplantar injection of SP600125 also
reduces inflammatory heat hyperalgesia induced by melittin, a major toxic peptide from bee
venom [21]. However, CFA-induced mechanical allodynia was not affected by either pre- or
post-treatment of intraplantar D-JNKI-1. Thus, peripheral JNK and central (spinal) JNK play
different role in regulating inflammatory pain symptoms, and peripheral JNK contributes only
to the induction of heat hyperalgesia.
4.2 JNK1 is the predominant isoform for mediating inflammatory pain
The JNK subfamily of MAPKs has three genes Jnk1, Jnk2 and Jnk3 encoding JNK1, JNK2,
and JNK3, respectively. While JNK1 and JNK2 are expressed in all tissues, JNK3 is
predominantly found in the CNS [44]. Mice deficient in a single isoform by targeted disruption
of Jnk1, Jnk2, or Jnk3 gene are viable, but mice lacking both Jnk1 and Jnk2 are embryonic
lethal [39]. Mice lacking Jnk3 display decreased susceptibility to kainic acid-induced seizures
and cell death in the hippocampus [69]. Axotomy-induced death of neonatal DRG neurons is
also reduced in Jnk3 deficient mice [37].
Our data showed that JNK1 is the major isoform activated in the spinal cord. Our previous
western analysis primarily detected pJNK1 band in the spinal cord [71]. The present study also
detected pJNK2 bands in the spinal cord, as a result of enhanced sensitivity of Western analysis.
Further, pJNK2 showed a marked increase after inflammation. Thus the role of JNK2 in
inflammatory pain should not be completely excluded. However, the levels of pJNK2 were
much lower than that of pJNK1 in all the spinal cord samples we examined. Since both JNK1
and JNK2 mutant mice show normal basal pain thresholds, the development of nociceptive
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pathway does not require these JNK isoforms. However, CFA-induced mechanical allodynia
is reduced in JNK1 but not JNK2 mutant mice, supporting a predominant role of JNK1 in
mediating inflammatory pain. Notably, JNK1 knockout mice only show a moderate reduction
in mechanical allodynia whereas JNK inhibitor largely reduces mechanical allodynia. This
discrepancy may result from a developmental compensation in JNK1-deficient mice. In
addition to JNK, other signaling molecules such ERK may also maintain mechanical allodynia
[27].
4.3. A correlation between CFA-induced bilateral JNK activation and bilateral mechanical
allodynia
Although CFA may induce polyarthritis several weeks later (>6 weeks) [7], we only observed
monoarthritis in the first several weeks we examined.. Our time course study showed that
unilateral CFA induced bilateral pain both in rats and mice, in support of previous studies in
the CFA model [3,5,51,57], but see [12]. Strikingly, only mechanical allodynia is bilateral,
whereas heat hyperalgesia remains to be ipsilateral. Moreover, heat hyperalgeisa is more
transient than mechanical allodynia (Fig. 7). In numerous clinical pain syndromes and diverse
animal models, pain hypersensitivity not only occurs in ipsilateral side, but also arises from
contralateral side [2,13,24,43,47,60,61,64,]. In particular, contralateral mechanical allodynia
is more common than heat hyperalgesia, although substance P, NMDA and non-NMDA
receptors, and dynorphin have been implicated in contralateral heat hyperalgesia [10,13,47].
In a sciatic inflammatory neuropathy (SIN) model, Milligan et al show that weak immune
activation produces unilateral allodynia whereas strong immune activation produces bilateral
allodynia [47]. Strong circumstantial evidence also points to a central mechanism of
mechanical allodynia [38].
Although many changes in mRNA/protein expression, such as spinal increase in c-Fos,
prodynorphin, and NK-1 after inflammation are largely ipsilateral [15,16,25,56], some spinal
changes are also bilateral. For example, formalin and CFA induce bilateral phosphorylation of
CREB [30,45]. CFA also induces bilateral up-regulation of Cox-2 mRNA that depends on
IL-1β [59]. Consistent with distinct role of peripheral and central JNK, COX-2 induction in
the spinal cord is important for the development of mechanical allodynia, whereas peripheral
COX-2 is certainly important for the development of heat hyperalgesia [65]. Our data showed
that CFA-induced JNK phosphorylation is also bilateral. Thus, bilateral induction of COX-2
and pJNK in the spinal cord may share similar upstream mechanisms, such as cytokine
dependence. Further, there is also a temporal correlation between bilateral JNK
phosphorylation and bilateral mechanical allodynia. Importantly, spinal inhibition of JNK can
attenuate CFA-induced bilateral mechanical allodynia. Indeed, the anti-allodynic effect of D-
JNKI-1 was more robust on the contralateral side (Fig. 5A,B). Therefore, it is reasonable to
postulate that bilateral JNK activation contributes to bilateral mechanical allodynia, especially
in the maintenance phase and contralateral side.
4.4. JNK and astrocyte network for mechanical allodynia and bilateral pain
It is generally believed that activation of large A-fibers (Aβ) are necessary for inducing
mechanical allodynia [29,41,55,67]. Low-threshold Aβ input can activate nociceptive
pathways after intense noxious stimulation and tissue injury [4,8,32,58]. Innocuous input also
activates PKCγ interneurons in the dorsal horn via myelinated afferent fibers [52].
Disinhibition of PKCγ neurons that receive innocuous input via Aβ fibers contributes to the
activation of nociceptive specific neurons in the superficial dorsal horn [49,50]. However, it
would be difficult to explain contralateral pain by these mechanisms.
Mounting evidence indicates that astrocytes play an important role in enhancing and
maintaining chronic pain [11,27,48,66]. Spinal astrocytes are persistently activated after nerve
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injury, spinal cord injury, and tumor growth [27]. Astrocytes are the most abundant cell type
in the CNS and have strong structural inter-relationship with neurons by enwrapping synaptic
terminals, enabling signaling between glia and neurons. In particular, astrocytes form
widespread networks via gap junctions and propagate calcium waves to a long distance [19,
23]. Gap junction blockade inhibits “mirror pain” (mechanical allodynia) in the contralateral
paw [62]. Thus, gap junction-mediated astrocyte networks may mediate mechanical allodynia
and contralateral pain, i.e. spread of pain beyond the initial injury site.
Previous studies reported that JNK is activated in spinal cord astrocytes after spinal nerve
ligation [71], partial sciatic nerve ligation [42], and amyotrophic lateral sclerosis [46]. Our
immunostaining results showed that pJNK and JNK1 are also expressed in spinal cord
astrocytes after inflammation, in agreement with previous studies [35,71]. Consistently, JNK1
is the predominant JNK isoform in cultured astrocytes [27]. Although we should not completely
exclude the possibility that JNK is activated in other spinal cell types after inflammation, our
data suggest that JNK1 activation in spinal astrocyte networks plays an important role in
mediating mechanical allodynia by producing proinflammatory and pronocicpetive mediators
[17] or modulating glutamate uptake [11]. For example, JNK-induced MCP-1 production in
spinal astrocytes can induce central sensitization and promote neuropathic pain [18].
4.5. Concluding remarks
Most drugs do not distinguish mechanical allodynia and heat hyperalgesia in animal models
of persistent pain. However, mechanical allodynia is more persistent than heat hyperalgesia
and spreads beyond the initial injury and even to the contralateral side. We have shown that
unilateral CFA induces a persistent and bilateral mechanical allodynia and this allodynia is
caused by bilateral activation of JNK, especially JNK1, in spinal cord astrocytes. Our data also
suggest that mechanical allodynia and spread of pain (contralateral pain) share similar
mechanisms, both involving JNK activation in astrocytes. In sharp contrast to spinal JNK that
is critical for the maintenance of mechanical allodynia, peripheral JNK contributes to the
induction of heat hyperalgesia. Therefore, targeting the JNK pathway may open a new avenue
for chronic pain management. In particular, JNK inhibitors, such as D-JNKI-1, at very low
doses, may be useful to alleviate some cardinal symptoms of chronic pain.
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Figure 1.
Time course of CFA-induced mechanical allodynia (A) and heat hypealgesia (B) in rats. CFA
produces rapid (<1 hour) and persistent (>2 weeks) mechanical allodynia in both ipsilateral
and contralateral paws (A). CFA only induces ipsilateral heat hyperalgesia, which largely
recovers after 2 weeks (B). *, P<0.05; **, P<0.01, compared to pre-CFA baseline, n = 6.
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Figure 2.
Western blot analysis showing time course of CFA-induced expression of pJNK1, pJNK2,
JNK1, and JNK2 in the spinal cord of rats. JNK1 and JNK2 are rapidly activated and maintained
for >14 days in both ipsilateral (A) and contralateral (B) lumbar spinal cord. Low panels in A
and B show densities of pJNK1 and pJNK2 bands after being normalized to tubulin. Total
levels of JNK1 and JNK2 do not change after inflammation (C). Low panels in C shows
densities of JNK1 and JNK2 against GAPDH. *, P<0.05; compared to naive animals, n = 4–
6.
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Figure 3.
Immunohistochemistry showing pJNK and JNK1 expression in spinal cord astrocytes of rats
after CFA injection. (A, B) CFA increases expression of pJNK in the spinal cord 3 days after
inflammation. (C) Colocalization of pJNK and GFAP (marker for astroglia) 3 days after CFA
injection. (D–F) Double staining shows a colocalization of JNK1 (D) and GFAP (E) in the
superficial spinal cord (laminae I–III) 3 days after CFA injection. Scale bars, 50 μm.
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Figure 4.
Intrathecal infusion of D-JNKI-1 via an osmotic pump reduces CFA-induced mechanical
allodynia in the maintenance phase in rats. (A) Structural organization of the D-JNKI-1 peptide.
The D-JNKI-1 (30 amino acids, aa) is a chimeric peptide starting with a 10-aa TAT transporter
sequence, followed by a 20-aa minimal JBD (JNK binding domain) sequence from the JIP1
molecule. (B) Pretreatment of D-JNKI-1, starting 2 days before inflammation, inhibits CFA-
induced mechanical allodynia in the maintenance phase (day 1 to day 4) but not in the induction
phase (6 h). (C) Pretreatment of D-JNKI-1 fails to alter CFA-induced heat hyperalgesia. D-
JNKI-1 (100 μM) or vehicle (PBS) infusion (1 μl/h, 1 week duration) started 2 days before
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CFA injection and ended 5 days after CFA injection. *, P<0.05, compared to vehicle control,
n = 5.
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Figure 5.
Reversal of CFA-induced mechanical allodynia in rats by intrathecal D-JNKI-1 and SP600125.
(A–C) A bolus injection of D-JNKI-1, given 3 days after CFA injection, dose-dependently
reduces mechanical allodynia on the ipsilateral (A) and contralateral (B) paws. Notice that the
anti-allodynic effects of D-JNKI-1 is more robust in the contralateral paws. D-JNKI-1 only
reduces CFA-induced unilateral heat hyperalgesia at the highest dose (C). *, P<0.05; **,
P<0.01; compared to corresponding saline control, n = 6–9. (D–F) A bolus injection of
SP600125 (20 nmol), given 3 days after CFA injection, reduces ipsilateral (D) and contralateral
(E) mechanical allodynia but not unilateral heat hyperalgesia (F). *, P<0.05, compared to
corresponding vehicle (10% DMSO) control, n = 5–6. (G) Western blotting showing a
reduction of spinal p-c-Jun levels, 3 h after SP600125 treatment. Right panel shows the density
of p-c-Jun band after being normalized to GAPDH. *, P<0.05, n = 6.
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Figure 6.
Peripheral (intraplantar) inhibition of JNK in rats reduces CFA-induced heat hyperalgesia in
the induction phase. (A, B) Pretreatment of D-JNKI-1 (10 nmol), 30 minutes before CFA
injection, attenuates CFA-induced heat hyperalgesia (A) but not mechanical allodynia (B). (C,
D) Posttreatment of intraplantar D-JNKI-1, 3 days after CFA, fails to reverse established heat
hyperalgesia (C) or mechanical allodynia (D). *, P<0.05, compared to saline control, n = 5.
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Figure 7.
Western blotting showing time course of CFA-induced pJNK1 and pJNK2 expression in the
spinal cord of mice. (A) CFA induced persistent increase (> 4 weeks) of JNK1 and JNK2 in
both ipsilateral and contralateral spinal cord. (B, C) Densities of pJNK1 (B) and pJNK2 (C) in
the spinal cord after being normalized to GAPDH. *, P<0.05, compared to naïve animals, n =
4–6.
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Figure 8.
CFA-induced mechanical allodynia is reduced in mice lacking JNK1. CFA produced rapid and
persistent bilateral mechanical allodynia (A, B) and ipsilateral heat hyperalgesia (C, D) in wild-
type mice. But in JNK1−/− mice, mechanical allodynia is attenuated bilaterally, especially in
the maintenance phase (A, B). CFA-induced heat hyperalgeisa is comparable in wild-type and
JNK1−/− mice (C, D). *, P<0.05; **, P<0.01; compared to wild type mice at the corresponding
time points. Notice that the baseline pain sensitivity is normal in the knockout mice. n = 7–8.
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Figure 9.
CFA-induced inflammatory pain is normal in mice lacking JNK2. CFA-induced mechanical
allodynia (A, B) and heat hyperalgesia (C, D) are comparable between JNK2−/− and wild-type
mice in all the time points examined. n = 5–6.
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